About Tada-lafil API Powder
| Tadlafil api powder |
IP/BP/USP
|
| Product Name |
Tadalafil
|
| Therapeutic Category |
Erectile dysfunction agent
|
| COA |
Available
|
| MSDS |
Available
|
| Minimum Order Quantity |
100 Kg
|
| Packaging Size |
As per requirement |
| Manufacturer |
Orbiton pharma |
| Composition |
Tadalafil api |
| Brand |
Orbiton's Tadalafil |
| Form |
API |
| Country of Origin |
Made in India |
| Minimum Order Quantity |
10Kg |
Product DescriptionTadalafil, sold under the brand name Cialis among others, is a medication used to treat erectile dysfunction, benign prostatic hyperplasia, and pulmonary arterial hypertension. It is a tablet taken by mouth. Onset is typically within half an hour and the duration is up to 36 hours.
Exceptional Purity and Safety StandardsThis Tada-lafil API powder features an impurity level of less than 0.10% and heavy metal content below 0.001%, ensuring it meets the rigorous standards set for pharmaceutical applications. It is compliant with ICH guidelines for residual solvents, and strict microbial limits are maintained with a total count below 1000 CFU/g and absence of pathogens, making it reliable for medicinal use.
Flexible Packaging and Extended Shelf LifeThe powder is securely packed in double polyethylene bags within fiber drums, available in 1 kg packs or tailored to your requirements. Its excellent stability grants it a shelf life of up to 36 months when stored in a cool, dry place in tightly closed containers, providing flexibility and convenience for bulk pharmaceutical buyers.
Ideal for Erectile Dysfunction TreatmentsWith a chemical profile matching reference standards (HPLC) and a specific rotation of +6.0 to +8.0, Tada-lafil API is the preferred ingredient for manufacturers developing medications for erectile dysfunction. Its high purity and consistent physical characteristics ensure reliable therapeutic performance and optimal patient benefits.
FAQ's of Tada-lafil API Powder:
Q: How is Tada-lafil API Powder commonly used in the pharmaceutical industry?
A: Tada-lafil API Powder is primarily utilized by pharmaceutical manufacturers in the production of oral dosage forms for the treatment of erectile dysfunction. Its high purity and compliance with international guidelines make it suitable for formulating safe and effective medicinal products.
Q: What benefits does this Tada-lafil API Powder offer compared to other sources?
A: The product offers superior purity (99%), minimal impurity levels (0.10%), and compliance with ICH residual solvent guidelines. Its rigorous specification ensures safety, stability, and reliability in final pharmaceutical formulations, reducing quality risks for manufacturers.
Q: When should Tada-lafil API Powder be stored or used after opening?
A: Once opened, the API powder should be used promptly or resealed tightly and kept in a cool, dry storage area to maintain its quality. The product remains stable for up to 36 months under recommended conditions.
Q: Where is Tada-lafil API Powder manufactured and supplied from?
A: This API is manufactured, exported, and supplied from India by reputable pharmaceutical suppliers and manufacturers, ensuring global accessibility and compliance with international quality standards.
Q: What processes ensure the safety and quality of Tada-lafil API Powder?
A: The powder undergoes stringent process controls, including impurity profiling (0.10%), HPLC identification, and compliance with microbial and residual solvent limits, to deliver a consistently safe and high-quality API.
Q: How should Tada-lafil API Powder be handled and stored to preserve its efficacy?
A: It should be handled in accordance with pharmaceutical guidelines: stored in tightly closed containers, away from moisture and heat, ideally in a cool, dry place. Double polyethylene bag packaging within fiber drums further protects its integrity.